Avanos Medical Inc (AVNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Sales | 172,200 | 164,200 | 169,900 | 165,100 | 160,900 |
Cost of Goods | 73,500 | 65,400 | 69,500 | 60,400 | 66,200 |
Gross Profit | 98,700 | 98,800 | 100,400 | 104,700 | 94,700 |
Operating Expenses | 109,000 | 123,800 | 109,200 | 98,100 | 86,100 |
Operating Income | -9,800 | -24,600 | -8,300 | 7,000 | 8,800 |
Interest Expense | 3,500 | 3,700 | 3,500 | 4,200 | 9,900 |
Other Income | 2,000 | 2,400 | 2,400 | 2,200 | 2,200 |
Pre-tax Income | -11,300 | -25,900 | -9,400 | 5,000 | 1,100 |
Income Tax | -3,300 | -5,600 | -6,700 | 800 | -200 |
Net Income Continuous | -8,000 | -20,300 | -2,700 | 4,200 | 1,300 |
Net Income Discontinuous | N/A | N/A | 500 | N/A | 34,000 |
Net Income | $-8,000 | $-20,300 | $-2,200 | $4,200 | $35,300 |
EPS Basic Total Ops | -0.17 | -0.43 | -0.05 | 0.09 | 0.75 |
EPS Basic Continuous Ops | -0.17 | -0.43 | -0.06 | 0.09 | 0.03 |
EPS Basic Discontinuous Ops | N/A | N/A | 0.01 | N/A | 0.72 |
EPS Diluted Total Ops | -0.17 | -0.43 | -0.03 | 0.09 | 0.73 |
EPS Diluted Continuous Ops | -0.17 | -0.43 | -0.06 | 0.09 | 0.03 |
EPS Diluted Discontinuous Ops | N/A | N/A | 0.03 | N/A | 0.70 |
EBITDA(a) | $-1,300 | $-16,200 | $700 | $15,900 | $16,600 |